# NAC Followed by RH for the Treatment of LACC

> **NCT03963882** · PHASE2 · UNKNOWN · sponsor: **Lei Li** · enrollment: 60 (estimated)

## Conditions studied

- Neoadjuvant Chemotherapy
- Locally Advanced Cervical Cancer
- Radical Hysterectomy
- Objective Response
- Laparoscopy
- Laparotomy
- Concurrent Chemoradiotherapy
- Adjuvant Therapy
- Systematic Chemotherapy

## Interventions

- **DRUG:** Two cycles of neoadjuvant chemotherapy
- **DIAGNOSTIC_TEST:** First imaging evaluation
- **DIAGNOSTIC_TEST:** Second imaging evaluation
- **DRUG:** The third cycles of neoadjuvant chemotherapy
- **PROCEDURE:** RH
- **RADIATION:** Radiochemotherapy
- **DIAGNOSTIC_TEST:** Pathologic evaluation

## Key facts

- **NCT ID:** NCT03963882
- **Lead sponsor:** Lei Li
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-19
- **Primary completion:** 2024-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03963882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03963882, "NAC Followed by RH for the Treatment of LACC". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03963882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*